首页 | 本学科首页   官方微博 | 高级检索  
检索        

重组人促红细胞生成素对尿毒症血清瘦素影响
引用本文:崔冰,韩建伟,姚孟英,丁海燕.重组人促红细胞生成素对尿毒症血清瘦素影响[J].医药论坛杂志,2005,26(4):30-31.
作者姓名:崔冰  韩建伟  姚孟英  丁海燕
作者单位:河南省南阳市中心医院肾内科,南阳市,473009;河南省南阳市电力医院肾内科,南阳市,473000
摘    要:目的观察重组人促红细胞生成素(rhuEPO)对维持性血液透析(MHD)的尿毒症患者血清瘦素水平的影响及其意义。方法38例行MHD的慢性肾衰竭(CRF)患者分为不用rhuEPO治疗组和使用rhuEPO治疗组;使用rhuEPO治疗的又分三组(2周组,4周组,8周组),采用放射免疫分析法测定血清瘦素水平。结果使用rhuEPO治疗8周后,血清瘦素水平明显低于治疗前及未用rhuEPO治疗组(P<0.05)。结论MHD患者的血清瘦素水平显著高于正常人群,注射rhuEPO后能显著降低患者血清瘦素水平,但不能降至正常人群的水平。

关 键 词:尿毒症  瘦素  重组人促红细胞生成素  血液透析
文章编号:1672-3422(2005)04-0030-02
修稿时间:2004年12月10

Changes of Serum Leptin Levels by rhuEPO in Chronic Renal Failure Hemodialysis
CUI Bing,HAN Jianwei,YAO Mengying,et al.Changes of Serum Leptin Levels by rhuEPO in Chronic Renal Failure Hemodialysis[J].Journal of Medical Forum,2005,26(4):30-31.
Authors:CUI Bing  HAN Jianwei  YAO Mengying  
Institution:CUI Bing,HAN Jianwei,YAO Mengying,et al Department of Nephrology,Nanyang Center Hospital,Nanyang 473009,China
Abstract:Objective To investigate the influence of erythropoietin (rhuEPO) on the serum leptin levels in chronic renal failure(CRF)hemodialysis (MHD) patients. Methods 38cases CRF patients conducted MHD were divided into two groups at random: non- rhuEPO treatment group and treatment with rhuEPO group that include 2 weeks group, 4 weeks group and 8 weeks group. Serum leptin was measured using radioimmunoassay. Results The serum leptin levels were significantly decreased after rhuEPO treatment 8weeks comparing with pretreatment and non-rhuEPO group (P<0.05). Conclusion The serum leptin levels of MHD patients are obviously higher than normal people,rhuEPO injection can decrease the serum leptin level,but not reach normal level.
Keywords:CRF  Serum leptin  rhuEPO  Hemodialysis
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号